Quotient Sciences Ltd
With trusted scientific insight brought to every program and 35+ years of ensuring quality & control throughout the development process, Quotient Sciences is a drug development & manufacturing accelerator helping clients bring molecules to cures, fast.
Services for drug product span from early phase to late-stage and commercial, and our clinical pharmacology services are focused on early phase, with a full suite of Phase I studies from first-in-human (FIH), single and multiple ascending dose (SAD / MAD) to regulatory and exploratory clinical studies including human ADME, TQT, DDI, and bioavailability studies.
We pioneered the integration of CRDMO services to create Translational Pharmaceutics®—a unique and disruptive platform that integrates drug product manufacturing & clinical testing for better clinical outcomes, reduced costs & timeline acceleration by up to 12 months.
Services for drug product span from early phase to late-stage and commercial, and our clinical pharmacology services are focused on early phase, with a full suite of Phase I studies from first-in-human (FIH), single and multiple ascending dose (SAD / MAD) to regulatory and exploratory clinical studies including human ADME, TQT, DDI, and bioavailability studies.
We pioneered the integration of CRDMO services to create Translational Pharmaceutics®—a unique and disruptive platform that integrates drug product manufacturing & clinical testing for better clinical outcomes, reduced costs & timeline acceleration by up to 12 months.